Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -32.11% | -23.42% | -11.79% | 1.73% | 15.90% |
| Total Depreciation and Amortization | 29.26% | 29.96% | 27.15% | 18.61% | 8.00% |
| Total Amortization of Deferred Charges | 128.90% | 44.40% | -42.63% | -19.07% | 6.89% |
| Total Other Non-Cash Items | 94.38% | 35.33% | -5.51% | -16.84% | -30.20% |
| Change in Net Operating Assets | -203.55% | -209.80% | -227.74% | 100.70% | 776.21% |
| Cash from Operations | -417.52% | -192.70% | -88.16% | 6.87% | 72.48% |
| Capital Expenditure | 89.33% | 87.48% | 87.27% | 73.62% | 60.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 78.78% | 60.61% | 46.07% | 33.08% | 21.98% |
| Cash from Investing | 79.27% | 62.57% | 50.01% | 36.79% | 25.35% |
| Total Debt Issued | -92.80% | -81.60% | -66.67% | -3.03% | 85.53% |
| Total Debt Repaid | 78.76% | 75.43% | 71.89% | -24.55% | -1,228.89% |
| Issuance of Common Stock | -- | 181.43% | 40.72% | -29.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | 0.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -235.65% | -67.83% | 16.09% | 100.00% |
| Cash from Financing | 326.22% | 92.00% | 23.55% | -32.75% | -78.73% |
| Foreign Exchange rate Adjustments | 417.07% | 401.09% | 364.52% | 126.19% | -14.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.11% | 207.92% | 224.92% | -289.32% | -1,023.80% |
